This is unpublished


Assistant Professor, Department of Dermatology
Director, Inpatient Dermatology Consultative Services
Sites of Practice
UW Medical Center – Roosevelt Dermatology Center


UW Medical Center – Roosevelt Dermatology Center 

Schedule Online

4225 Roosevelt Way NE, Floor 4
Seattle, WA 98105



Dr. Anna Cogen is a board-certified dermatologist with an interest in infectious diseases in dermatology and complex medical dermatology. She sees patients at the UW Medical Center– Roosevelt Clinic and serves as the Director of Inpatient Dermatology Consultative Service at the UW Medical Center– Montlake Hospital.  

Dr. Cogen’s research interests include cutaneous leishmaniasis and neutrophilic dermatoses. She is also involved in the development of medical student curriculum and resident/med student inpatient dermatology education.  

Dr. Cogen is a member of the Seattle Dermatology Society, Women’s Dermatologic Society, and the American Academy of Dermatology. 

Education & Training

Residency in Dermatology, University of Pennsylvania, Philadelphia PA  (2016-2019)

Medical Internship, Virginia Mason Medical Center, Seattle WA (2015-2016)

MD, University of California, San Francisco, San Francisco, CA (2011-2015)

PhD, University of California San Diego (2004-2009)

Bachelor of Science, University of California, Santa Barbara, Santa Barbara, CA (1998-2002)


Edward Bondi Resident Teaching Award (2018) 

Women’s Dermatologic Society Mentorship Award (2018) 

Research Interests

  • Treatment of Leprosy reactions
  • Cutaneous Leishmaniasis
  • Clinical trial of Mavorixafor in WHIM syndrome

Clinical Interests

  • Infectious Diseases in Dermatology
  • Inpatient Dermatology
  • Complex Medical Dermatology
  • Medical Education



Selected Publications

Cogen AL, Lebas E, De Barros B, Harnisch JP, Faber WR, Lockwood DN, Walker SL. Biologics in Leprosy: A Systematic Review and Case Report. Am J Trop Med Hyg. 2020 May; 102 (5):1131-1136.

Cogen AL, Desai K, Elder, D, Rosenbach, M. Acute Photodistributed Exanthematous Pustulosis due to Liraglutide. JAMA Dermatol. 2019, Aug 7.

Cogen AL, Parkekh V, Gangadhar, T, Lipoff, JB. Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma. JAAD Case Rep. 2018 Jan 16; 4(2) 132-134.

Cogen AL, Walker SL, Roberts Ch, Hagge DA, Khadge S, Neupane KD, Lockwood DNJ. Human Beta-Defensins 2 and 3 are up-regulated in cutaneous leprosy Type 1 reactions. PLoS Negl Trop Dis. 2012 Nov;6(11): e1869.